Position in AVXL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$726,988
+$367,357 QoQ
Shares Held
236,804
+134.4% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. AVXL ranks #52 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,940,885 | $84,099,887 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
161,052 | $71,916,158 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,907 | $37,787,502 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,514 | $26,375,120 | |
| 5 | OMER |
Omeros Corp
|
1,831,585 | $19,341,536 | |
| 6 | MANE |
Veradermics, Inc
|
294,117 | $18,573,488 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49,954 | $16,528,277 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
196,703 | $14,770,427 |
All Filings in AVXL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $726,988 | 236,804 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $359,631 | 101,020 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $460,939 | 51,791 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $443,398 | 48,091 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $391,221 | 45,597 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||